Gorini Giuseppe, Carreras Giulia, Lugo Alessandra, Gallus Silvano, Masocco Maria, Spizzichino Lorenzo, Minardi Valentina
Oncologic network, prevention and research institute (ISPRO), Florence, Italy.
Oncologic network, prevention and research institute (ISPRO), Florence, Italy.
Prev Med. 2023 Jan;166:107391. doi: 10.1016/j.ypmed.2022.107391. Epub 2022 Dec 15.
This paper updates a previous cross-sectional study on the effectiveness of electronic cigarettes (e-cigarettes) as an aid to quit smoking. In the 2014-2021 PASSI survey, the ongoing Italian behavioural risk factor surveillance system, on a total of 239,812 subjects representative of the Italian adult population respondents who smoked and made at least one quit attempt in the previous 12 months (i.e., 19,234 subjects) were categorized into four groups according to the method used in their most recent quit attempt: no aid, e-cigarettes, standard pharmacological support (medications) and/or smoking cessation services (SCSs), other unspecified methods. The primary outcome was self-reported abstinence for a period ≥6 months. Thirteen percent of participants used e-cigarettes to quit, 83% no aid, 2% medications/SCSs, 3% other unspecified methods. Smoking abstinence was reported among 10% of those using no aid; 11% among e-cigarette users; 16% among those using medications/SCSs; and 13% among those using other unspecified methods. No significant difference in abstinence was observed for those reporting no aid compared with e-cigarette users (adjusted Prevalence Ratio [aPR] = 0.93; 95% confidence interval [CI] = 0.79-1.10). Those using medications/SCSs were significantly more likely to report abstinence than e-cigarette users (aPR = 1.35; 95% CI = 1.01-1.81). E-cigarettes as consumer products are not associated with higher quitting rates than those recorded using no aid, therefore there is no health benefit for allowing them to be marketed to smokers.
本文更新了一项关于电子烟作为戒烟辅助手段有效性的横断面研究。在2014 - 2021年的PASSI调查中，即正在进行的意大利行为风险因素监测系统，在总共239,812名代表意大利成年人口的受访者中，那些吸烟且在过去12个月内至少尝试戒烟一次的人（即19,234名受试者），根据他们最近一次戒烟尝试所使用的方法被分为四组：无辅助手段、电子烟、标准药物支持（药物）和/或戒烟服务（SCS）、其他未明确说明的方法。主要结局是自我报告的持续≥6个月的戒烟情况。13%的参与者使用电子烟戒烟，83%无辅助手段，2%使用药物/SCS，3%使用其他未明确说明的方法。在无辅助手段的人中，有10%报告戒烟；电子烟使用者中有11%；使用药物/SCS的人中有16%；使用其他未明确说明方法的人中有13%。与电子烟使用者相比，报告无辅助手段的人在戒烟方面未观察到显著差异（调整后患病率比[aPR]=0.93；95%置信区间[CI]=0.79 - 1.10）。使用药物/SCS的人比电子烟使用者更有可能报告戒烟（aPR = 1.35；95% CI = 1.01 - 1.81）。作为消费品的电子烟与不使用辅助手段相比，并未带来更高的戒烟率，因此允许其向吸烟者销售并无健康益处。
